Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF-alpha) signaling pathway
A Standard patent application filed on 06 April 2000 credited to Searfoss, George H. III
;
Pagnoni, Marco F.
;
Clark, Kenneth L.
;
Guo, Kun
;
Ivashchenko, Yuri D.
Details
Application number :
40768
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF-alpha) signaling pathway
Inventor :
Searfoss, George H. III
;
Pagnoni, Marco F.
;
Clark, Kenneth L.
;
Guo, Kun
;
Ivashchenko, Yuri D.
Agent name :
WATERMARK PATENT AND TRADE MARKS ATTORNEYS
Address for service :
Level 2 302 Burwood Road HAWTHORN VIC 3122
Filing date :
06 April 2000
Associated companies :
Applicant name :
Aventis Pharmaceuticals Inc.
Applicant address :
500 Arcola Road, Collegeville, Pennsylvania 19426-0107, United States Of America